AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.610
+0.020 (0.56%)
At close: Feb 27, 2026, 4:00 PM EST
3.700
+0.090 (2.50%)
After-hours: Feb 27, 2026, 7:59 PM EST
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.09 billion as of February 27, 2026. Its market cap has increased by 19.52% in one year.
Market Cap
1.09B
Enterprise Value
703.80M
1-Year Change
19.52%
Ranking
Category
Stock Price
$3.61
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.09B, a decrease of -93.01%. That is a compound annual growth rate of -39.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.09B | 6.90% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 1.13B |
| Sana Biotechnology | 1.12B |
| Day One Biopharmaceuticals | 1.09B |
| Inhibrx Biosciences | 1.08B |
| Geron | 1.07B |
| Bicara Therapeutics | 1.06B |
| Aktis Oncology | 1.06B |
| UroGen Pharma | 1.02B |